21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021
Oct 12, 2023
Age-standardized prevalence rates were higher among women than men, veterans than nonveterans and non-Hispanic whites.
Gantenerumab does not slow clinical decline in early Alzheimer’s disease
Nov 16, 2023
Two trials show a lower amyloid plaque burden with gantenerumab versus placebo at 116 weeks.
Endocrine, vascular processes contribute to cognitive decline in women
Apr 03, 2024
Earlier menopause and higher vascular risk were synergistically associated with lower cognitive scores at follow-up.
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Postoperative cognitive issues common among middle-aged surgery patients
Oct 12, 2023
The researchers found that the 8-Item Informant Interview to Differentiate Aging and Dementia (AD8) abnormality incidence rates after noncardiac surgery increased from 2.2% at seven days to 17.1% at six...
Long-term study of postmenopausal women does not support many preventive therapies
May 02, 2024
Hormone therapy was no aid for cardiovascular disease prevention, and calcium/vitamin D supplementation was no aid for universal fracture prevention.